《大行》摩通一舉升敏實(00425.HK)目標價至40元 中期盈利增長穩健
摩根大通發表研究報告指,敏實集團(00425.HK)今年以來股價累升130%,對比同期恆指升幅爲26%,主要來自於香港股市流動性改善、公司恢復派息及歐洲電動車銷售趨勢勝預期等帶動。
敏實上半年收入增長11%及盈利增長約20%,表現穩健,大致符合公司指引及市場預期。摩通表示,曾於今年4月因應美國關稅不確定性下汽車產量潛在疲弱,下調敏實盈利預測12%,現時美國汽車產量預期已從谷底回升,相應將2025及2026年盈利預測上調13%及12%,維持「增持」評級,將目標價從25元一舉上調至40元,對應預測2026年市盈率約13.5倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.